Osaic Holdings’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.29K | Hold |
2,706
| – | – | ﹤0.01% | 5874 |
|
|
2025
Q1 | $5.82K | Buy |
2,706
+61
| +2% | +$131 | ﹤0.01% | 6014 |
|
|
2024
Q4 | $8.07K | Buy |
2,645
+2,633
| +21,942% | +$8.03K | ﹤0.01% | 5842 |
|
|
2024
Q3 | $28 | Hold |
12
| – | – | ﹤0.01% | 7089 |
|
|
2024
Q2 | $33 | Sell |
12
-20
| -63% | -$55 | ﹤0.01% | 7101 |
|
|
2024
Q1 | $142 | Sell |
32
-2
| -6% | -$9 | ﹤0.01% | 6815 |
|
|
2023
Q4 | $258 | Sell |
34
-8
| -19% | -$61 | ﹤0.01% | 6838 |
|
|
2023
Q3 | $305 | Buy |
42
+8
| +24% | +$58 | ﹤0.01% | 6913 |
|
|
2023
Q2 | $316 | Hold |
34
| – | – | ﹤0.01% | 6983 |
|
|
2023
Q1 | $559 | Sell |
34
-3
| -8% | -$49 | ﹤0.01% | 6982 |
|
|
2022
Q4 | $1.01K | Hold |
37
| – | – | ﹤0.01% | 6752 |
|
|
2022
Q3 | $1K | Hold |
37
| – | – | ﹤0.01% | 6894 |
|
|
2022
Q2 | $4K | Buy |
37
+2
| +6% | +$216 | ﹤0.01% | 6550 |
|
|
2022
Q1 | $4K | Sell |
35
-20
| -36% | -$2.29K | ﹤0.01% | 6506 |
|
|
2021
Q4 | $6K | Hold |
55
| – | – | ﹤0.01% | 6452 |
|
|
2021
Q3 | $11K | Sell |
55
-43
| -44% | -$8.6K | ﹤0.01% | 6124 |
|
|
2021
Q2 | $45K | Buy |
98
+51
| +109% | +$23.4K | ﹤0.01% | 5111 |
|
|
2021
Q1 | $10K | Buy |
+47
| New | +$10K | ﹤0.01% | 5827 |
|